open access

Vol 11, Supp. C (2015)
suplement
Get Citation

Toxicity after abiraterone acetate treatment of a patient with advanced prostate cancer — a case study

Jolanta Korczak

open access

Vol 11, Supp. C (2015)
suplement

Abstract

The description presents a 69-year-old man with prostate cancer, who despite the lack of primary radical treatment of local disease benefited from hormonotherapy, and after resistance to castration also from chemotherapy. Despite significantly advanced disease, rapidly increasing PSA antigen level, the patient remained asymptomatic for 8 years. The administration of treatment with abiraterone acetate allowed to obtain biochemical response, though it revealed meaningful cardiologic toxicity preventing from further treatment.

Abstract

The description presents a 69-year-old man with prostate cancer, who despite the lack of primary radical treatment of local disease benefited from hormonotherapy, and after resistance to castration also from chemotherapy. Despite significantly advanced disease, rapidly increasing PSA antigen level, the patient remained asymptomatic for 8 years. The administration of treatment with abiraterone acetate allowed to obtain biochemical response, though it revealed meaningful cardiologic toxicity preventing from further treatment.

Get Citation

Keywords

prostate cancer, hormonotherapy, quality of life chemotherapy, abiraterone acetate

About this article
Title

Toxicity after abiraterone acetate treatment of a patient with advanced prostate cancer — a case study

Journal

Oncology in Clinical Practice

Issue

Vol 11, Supp. C (2015)

Keywords

prostate cancer
hormonotherapy
quality of life chemotherapy
abiraterone acetate

Authors

Jolanta Korczak

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl